39

PetIQ IncDUS PetIQ Stock Report

Last reporting period 30 Jun, 2024

Updated 24 Oct, 2024

Last price

Market cap $B

0.913

Micro

Exchange

XDUS - Boerse Duesseldorf

39L.DU Stock Analysis

39

Uncovered

PetIQ Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

27/100

Low score

Market cap $B

0.913

Dividend yield

Shares outstanding

28.974 B

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,888 full-time employees. The company went IPO on 2017-07-21. The firm is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The firm has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. The company is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. The company offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks.

View Section: Eyestock Rating